Natco Pharma Ltd

Natco Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Natco Pharma Ltd

₹ 1,215 1.93%
03 Jul 9:50 a.m.
natcopharma.co.in BSE: 524816 NSE: NATCOPHARM
About

NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas. [1]
NATCO has established its presence in all three business segments viz. finished dosage formulations (“FDF”), active pharmaceutical ingredients (“APIs”), Contract Manufacturing Business.[2]

Key Points

Exports of formulations - Complex Generics [1]
The company is focused on niche opportunities in the US.
Focus on Para IV and First-to-File molecules
Started winning tenders in Asian markets including Malaysia and Thailand

Company is focused on high-barrier-to-entry products that are typically characterized by one or more of the following: Intricate Chemistry, Challenging delivery systems, Difficult or complex manufacturing process

Website BSE NSE
  • Market Cap ₹ 21,762 Cr.
  • Current Price ₹ 1,215
  • High / Low ₹ 1,259 / 667
  • Stock P/E 16.7
  • Book Value ₹ 312
  • Dividend Yield 0.80 %
  • ROCE 29.0 %
  • ROE 25.4 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company has been maintaining a healthy dividend payout of 29.3%

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
312 394 330 530 514 806 351 413 781 1,048 930 625 965
235 280 281 442 552 426 281 346 454 545 488 387 512
Operating Profit 76 114 49 88 -38 379 70 68 328 504 442 238 453
OPM % 25% 29% 15% 17% -7% 47% 20% 16% 42% 48% 48% 38% 47%
29 12 40 32 10 33 16 19 18 15 25 30 36
Interest 2 2 3 4 4 3 2 3 1 3 3 4 4
Depreciation 30 33 34 36 36 37 38 38 38 40 40 40 52
Profit before tax 73 91 52 80 -67 373 46 45 306 475 424 224 432
Tax % 22% 17% -2% 10% 9% 17% 19% 17% 17% 15% 15% 14% 19%
57 75 54 72 -61 308 38 37 254 405 360 192 349
EPS in Rs 3.14 4.12 2.94 3.93 -3.36 16.87 2.07 2.04 13.92 22.63 20.11 10.72 19.49
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
558 622 716 1,059 1,958 2,091 1,986 1,790 1,654 1,768 2,351 3,569
401 436 487 778 1,266 1,163 1,170 1,212 1,236 1,555 1,506 1,932
Operating Profit 157 187 229 281 692 928 816 578 418 213 845 1,637
OPM % 28% 30% 32% 26% 35% 44% 41% 32% 25% 12% 36% 46%
0 16 -2 13 13 39 130 124 101 95 86 105
Interest 25 34 30 22 18 15 19 21 11 13 9 14
Depreciation 20 27 42 50 54 66 80 98 115 138 151 172
Profit before tax 112 141 154 222 634 888 847 583 392 156 771 1,555
Tax % 30% 22% 1% 20% 22% 21% 21% 19% 21% 11% 17% 16%
78 110 153 176 495 698 667 474 310 139 637 1,307
EPS in Rs 4.98 6.66 9.20 10.13 28.39 37.84 36.48 26.06 16.97 7.62 34.90 72.95
Dividend Payout % 16% 15% 11% 12% 24% 22% 17% 26% 31% 59% 16% 13%
Compounded Sales Growth
10 Years: 19%
5 Years: 12%
3 Years: 29%
TTM: 52%
Compounded Profit Growth
10 Years: 28%
5 Years: 15%
3 Years: 66%
TTM: 110%
Stock Price CAGR
10 Years: 20%
5 Years: 18%
3 Years: 1%
1 Year: 72%
Return on Equity
10 Years: 16%
5 Years: 13%
3 Years: 15%
Last Year: 25%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 31 33 33 35 35 37 36 36 36 36 36 36
Reserves 506 700 846 1,302 1,665 3,088 3,527 3,833 4,055 4,155 4,666 5,556
336 237 309 110 221 173 384 314 256 400 161 366
184 206 207 396 427 438 408 463 405 387 525 596
Total Liabilities 1,057 1,176 1,395 1,843 2,347 3,736 4,356 4,647 4,752 4,978 5,388 6,554
471 529 573 706 829 1,015 1,215 1,574 2,006 2,174 2,234 2,287
CWIP 78 93 101 212 336 480 638 518 223 129 63 134
Investments 78 89 131 94 95 150 244 191 337 550 658 742
431 465 590 831 1,087 2,091 2,259 2,363 2,186 2,125 2,434 3,392
Total Assets 1,057 1,176 1,395 1,843 2,347 3,736 4,356 4,647 4,752 4,978 5,388 6,554

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
70 172 125 190 330 476 699 422 184 58 784 1,196
-123 -131 -148 -248 -291 -1,131 -645 -165 -3 -92 -437 -960
29 -41 23 151 -46 652 -52 -261 -183 36 -347 -237
Net Cash Flow -24 0 -1 93 -6 -3 1 -4 -3 1 1 -1

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 83 68 96 88 87 106 90 109 88 119 123 110
Inventory Days 284 392 424 501 215 400 547 482 562 476 424 379
Days Payable 213 240 247 385 160 231 217 215 102 96 126 116
Cash Conversion Cycle 153 220 274 205 142 275 420 376 548 499 422 373
Working Capital Days 75 78 106 119 114 252 285 374 353 348 238 207
ROCE % 18% 19% 18% 18% 39% 34% 24% 14% 9% 3% 16%

Shareholding Pattern

Numbers in percentages

8 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
48.87% 48.87% 48.86% 48.81% 48.80% 48.80% 48.82% 48.84% 49.76% 49.71% 49.71% 49.71%
13.73% 12.53% 12.26% 11.94% 11.65% 11.67% 11.73% 11.91% 11.03% 12.82% 13.72% 16.14%
16.21% 17.78% 18.08% 16.15% 15.30% 14.30% 14.93% 15.38% 15.15% 14.01% 11.26% 9.69%
21.19% 20.82% 20.80% 23.10% 24.25% 25.23% 24.53% 23.87% 24.08% 23.48% 25.32% 24.46%
No. of Shareholders 87,66788,43988,42185,82892,4491,21,3361,35,3971,53,6631,55,1811,63,7532,07,5712,28,467

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls